Stocks · Health care · Pharmaceutical Preparations

PALVELLA THERAPEUTICS, INC.

PVLA Clue Score43

United States Fiscal year ends December CIK 0001583648 Results filed 5 Nov 2026

Add to watchlist

What the insiders did Net selling

By person

13 insiders · 96 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Orbimed Advisors LLC entity

10% owner

—

$19.83M (8)

−$19.83M

38,870

0.2698%

$4.91M

−98.6%

George M Jenkins

Director

$702.49K (5)

$7.75M (26) scheduled

−$7.04M

159,648

1.11%

$20.15M

−20.7%

Kathleen Goin

Chief Operating Officer

—

$6.04M (36) scheduled

−$6.04M

0

0.0000%

$0.00

—

Aquilo Capital Management, LLC entity

10% owner

—

$5.61M (1)

−$5.61M

3,675,530

25.51%

$463.83M

−34.1%

Allan Reine

Chief Financial Officer

$313.35K (2)

—

+$313.35K

65,000

0.4511%

$8.20M

—

Elaine J Heron

Director

$300.00K (1)

—

+$300.00K

47,812

0.3318%

$6.03M

+5.3%

Bvf Partners L P/Il entity

See Explanation of Responses

—

$224.97K (3)

−$224.97K

38,961

0.2704%

$4.92M

−99.2%

Shane Olwill

Chief Development Officer

—

$196.38K (2) scheduled

−$196.38K

4,638

0.0322%

$585.29K

0.0%

James A Geraghty

Director

$105.70K (3)

—

+$105.70K

20,000

0.1388%

$2.52M

—

ADAR1 Capital Management, LLC entity

10% owner

$92.33K (3)

—

+$92.33K

15,067

0.1046%

$1.90M

+66.2%

Christopher P Kiritsy

Director

$34.03K (2)

$49.14K (1) scheduled

−$15.12K

250

0.0017%

$31.55K

—

Tim Demuth

Chief Medical Officer

$10.26K (1)

—

+$10.26K

6,000

0.0416%

$757.17K

—

Matthew E Korenberg

CFO, Treasurer

—

—

—

1,000

0.0069%

$126.19K

—